Search Results - "Cam, Gulsum"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Clinical characteristics and risk factors associated with severe disease and outcome of patients with COVID-19 by Ozel, Ayse Serra, Altunal, Lutfiye Nilsun, Aydin, Mehtap, Unal, Busra, Cam, Gulsum, Caglar Ozer, Merve, Korten, Volkan

    “…Since the beginning of the pandemic, factors associated with mortality in patients with corona virus infection disease 2019 (COVID-19) have been investigated…”
    Get full text
    Journal Article
  2. 2

    Evaluation of Tetanus Seropositivity in Healthcare Professionals by Age and Occupational Groups by Cam, Gulsum, Ozel, Ayse Serra, Kadanali, Ayten

    Published in KLIMIK dergisi (01-12-2022)
    “…Objective: Our country has limited data on protective antibody levels following primary tetanus immunization. In this study, we planned to evaluate the tetanus…”
    Get full text
    Journal Article
  3. 3

    Evaluation of Tetanus Seropositivity in Healthcare Professionals by Age and Occupational Groups/Saglik Calisanlarinda Tetanos Seropozitifliginin Yas ve Meslek Gruplarina Gore Degerlendirilmesi by Cam, Gulsum, Ozel, Ayse Serra, Kadanali, Ayten

    Published in KLIMIK dergisi (01-12-2022)
    “…Objective: Our country has limited data on protective antibody levels following primary tetanus immunization. In this study, we planned to evaluate the tetanus…”
    Get full text
    Journal Article
  4. 4

    Evaluation of Modified ATRIA Risk Score in Predicting Mortality in Hospitalized Patients With COVID-19 by Aciksari, Gonul, Cetinkal, Gokhan, Kocak, Mehmet, Cag, Yasemin, Atici, Adem, Altunal, Lutfiye Nilsun, Barman, Hasan Ali, Aydin, Mehtap, Kocas, Betul Balaban, Cam, Gulsum, Guclu, Kader Gorkem, Caliskan, Mustafa

    “…As the Modified Anticoagulation and Risk Factors in Atrial Fibrillation Risk Score (M-ATRIA-RS) encompasses prognostic risk factors of novel coronavirus-2019…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Appropriate Use of Tocilizumab in COVID-19: Early Use is Beneficial by Altunal, Lütfiye Nilsun, Aydın, Mehtap, Özel, Ayşe Serra, Çam, Gülsüm

    “…Interleukin-6 inhibitor Tocilizumab (TCZ) is effective to prevent the mortality of severe COVID-19 by suppressing the cytokine storm, however, its appropriate…”
    Get full text
    Journal Article